Question 1

What is combined oxidative phosphorylation deficiency 58?

Accepted Answer

Combined oxidative phosphorylation deficiency 58 is a multisystem disorder that affects several organ systems including the central nervous system, muscles, and the eyes. It is caused by pathogenic variants in the TEFM gene, which plays a critical role in mitochondrial transcription and energy production. Affected individuals typically present in early childhood with developmental delays and other metabolic and neurological symptoms. Prevalence details are not well established, and the condition is inherited in an autosomal dominant pattern.

Question 2

What are the symptoms of combined oxidative phosphorylation deficiency 58?

Accepted Answer

The clinical presentation is marked by a number of consistent features. Virtually all affected individuals experience vomiting, a thin corpus callosum, ophthalmoparesis, hyperalaninemia, visual loss, microcephaly, increased circulating lactate, lacticaciduria, cerebellar atrophy, hypoglycemia, and evidence of central nervous system demyelination. Additional findings include global developmental delay, delayed speech and language development, ataxia, elevated brain lactate levels detected by MRS, and abnormalities on EMG studies. There may also be intellectual disability, ragged-red muscle fibers, and strabismus in a subset of individuals. Cognitive and neurological challenges are prominent, and overall, not all individuals experience all features, with severity varying considerably.

Question 3

What causes combined oxidative phosphorylation deficiency 58?

Accepted Answer

This condition is caused by pathogenic variants in the TEFM gene, which is essential for the proper elongation of mitochondrial transcripts and subsequent energy production. Disruption of this gene impairs mitochondrial protein synthesis, leading to decreased activity of mitochondrial complexes and the metabolic abnormalities observed in affected individuals. The condition is inherited in an autosomal dominant pattern, meaning that a single altered copy of the gene can result in the disorder and that an affected individual has a 50% chance of passing the variant to their offspring. Genetic counseling is recommended for families to understand these implications. Associated genes include TEFM.

Question 4

How is combined oxidative phosphorylation deficiency 58 inherited?

Accepted Answer

combined oxidative phosphorylation deficiency 58 follows an autosomal dominant inheritance pattern. This means inheriting just one copy of the altered gene from either parent can cause the condition.

Question 5

How is combined oxidative phosphorylation deficiency 58 diagnosed?

Accepted Answer

Definitive diagnosis is achieved through molecular genetic testing that identifies pathogenic variants in the TEFM gene. The evaluation is supported by clinical findings such as global developmental delay, specific neuroimaging abnormalities, and metabolic disturbances including elevated lactate and hyperalaninemia. Because many of these features can overlap with other metabolic and mitochondrial disorders, genetic testing is essential to confirm the diagnosis and distinguish it from similar conditions.

Question 6

Are there treatments for combined oxidative phosphorylation deficiency 58?

Accepted Answer

Currently, management focuses on supportive care and symptom management, as there are no treatments specifically approved for combined oxidative phosphorylation deficiency 58. Treatment is tailored to the individual and may include strategies to manage hypoglycemia, support developmental progress, and address ophthalmologic and neurological issues. Long-term care involves regular surveillance to detect and manage emerging complications, and a multidisciplinary team is typically involved in care planning. Patients and families are encouraged to discuss the range of supportive therapies and obtain genetic counseling to understand treatment options and family planning considerations.

Question 7

What complications can arise from combined oxidative phosphorylation deficiency 58?

Accepted Answer

Individuals with combined oxidative phosphorylation deficiency 58 may experience a range of complications over time. These can include worsening neurological symptoms, increased developmental delays, and potential vision loss. Regular monitoring is important to manage these complications and to provide supportive care as needed.

Question 8

How does combined oxidative phosphorylation deficiency 58 affect daily life for patients and families?

Accepted Answer

Living with combined oxidative phosphorylation deficiency 58 can be challenging for both patients and their families. Daily life may involve managing symptoms like developmental delays and neurological issues, which can require special education and therapy. Families often need to coordinate care with various specialists to ensure the best support for their loved one.

Question 9

What is the long-term outlook for someone with combined oxidative phosphorylation deficiency 58?

Accepted Answer

The long-term outlook for individuals with combined oxidative phosphorylation deficiency 58 varies widely. Some may experience stable periods, while others might face ongoing challenges and complications. With supportive care and regular monitoring, many individuals can improve their quality of life, but the specific prognosis can differ greatly from person to person.

Question 10

Are there specific specialists recommended for managing combined oxidative phosphorylation deficiency 58?

Accepted Answer

Yes, it is recommended that individuals with combined oxidative phosphorylation deficiency 58 see a team of specialists for comprehensive care. This may include neurologists, geneticists, and metabolic specialists who understand the complexities of the condition. A multidisciplinary approach helps address the various symptoms and challenges associated with the disorder.

Research Type	Count	% of Total
Laboratory research	17	57%

Kisho

combined oxidative phosphorylation deficiency 58

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

combined oxidative phosphorylation deficiency 58

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation deficiency 58?

What are the symptoms of combined oxidative phosphorylation deficiency 58?

What causes combined oxidative phosphorylation deficiency 58?

How is combined oxidative phosphorylation deficiency 58 inherited?

How is combined oxidative phosphorylation deficiency 58 diagnosed?

Are there treatments for combined oxidative phosphorylation deficiency 58?

What complications can arise from combined oxidative phosphorylation deficiency 58?

How does combined oxidative phosphorylation deficiency 58 affect daily life for patients and families?

What is the long-term outlook for someone with combined oxidative phosphorylation deficiency 58?

Are there specific specialists recommended for managing combined oxidative phosphorylation deficiency 58?

Explore clinical features

Recent Publications